Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check7 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
- Check14 days agoChange DetectedThe website has added new estimated update dates for 2025 and a revision update to v2.14.2, while removing several entries from late 2024, including the previous revision v2.14.1.SummaryDifference0.8%
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.0%
- Check36 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check65 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check72 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the locations where the study is taking place.SummaryDifference2%
Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.